Thermo Fisher Scientific TMO · USD
Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States
S&P 500
721.63
+3.87%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Thermo Fisher Scientific
From its filings with the US Securities and Exchange Commission
Thermo Fisher Scientific is based in Waltham, Massachusetts and is incorporated in Delaware. Its shares trade on NYSE under the ticker TMO. It is a member of the S&P 500. The SEC classifies its business as measuring & controlling devices, nec. In the fiscal year to 31 December 2025, it reported revenue of $44.56bn and net income of $6.70bn. At that date it held total assets of $110.34bn and shareholders' equity of $53.41bn.
Thermo Fisher Scientific Inc. (also referred to in this document as “Thermo Fisher,” “we,” the “company,” or the “registrant”) is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. We serve customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
We continuously increase our depth of capabilities across our broad portfolio of innovative products and services and leverage our extensive global channels to address our customers’ needs. We do this through organic investments in research and development, capacity and capabilities and through acquisitions. Our goal is to enable our customers to be more productive in an increasingly competitive business environment, enable them to accelerate innovation, solve their challenges and advance their important work.
Quoted from its 10-K, filed 26 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 27 Aug 1980
- Employees
- 125,000
- Website
- thermofisher.com ↗
- Head office
- 168 THIRD AVENUE, WALTHAM, MA, 02451
- Incorporated in
- DE
- Classification
- Measuring & Controlling Devices, NEC
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Marc CasperChairman of the Board, President, Chief Executive Officer, since 2001$30.4m
- Mr. Stephen WilliamsonChief Financial Officer, Senior Vice President$11.1m
- Mr. Michel LagardeChief Operating Officer, Executive Vice President$12.8m
- Ms. Lisa BrittChief Human Resources Officer, Senior Vice President$2.9m
- Mr. Frederick LoweryExecutive Vice President$8.5m
- Mr. Gianluca PettitiExecutive Vice President, since 2021$11.3m
- Mr. Michael ShaferExecutive Vice President
- Mr. Michael BoxerSenior Vice President, General Counsel$3.1m
- Mr. Joseph HolmesChief Accounting Officer, Vice President
- Mr. Scott SperlingLead Independent Director$406,520
- Dr. Tyler JacksDirector$345,836
- Mr. Nelson ChaiIndependent Director$365,836
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 88
- Environment
- 99
- Social
- 99
- Governance
- 65
- Direct emissions (scope 1)
- 331,463 t
- Energy emissions (scope 2)
- 427,904 t
- Value chain emissions (scope 3)
- 11,320,351 t
- Women in the workforce
- 48%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Thermo Fisher Scientific Inc offers a diverse portfolio of products, including scientific instruments, consumables, reagents, software, and services. This extensive range allows them to cater to the needs of various industries and customers, providing a strong competitive advantage.
- Thermo Fisher Scientific Inc has established a strong brand reputation in the scientific research and healthcare sectors. Their commitment to innovation, quality, and reliability has earned the trust of customers worldwide, boosting their market position and customer loyalty.
- Thermo Fisher Scientific Inc operates globally and has a well-established distribution network. Their wide geographic presence allows them to reach customers worldwide efficiently and effectively, contributing to their market share dominance and revenue growth.
Weaknesses
- Thermo Fisher Scientific Inc heavily relies on continuous research and development activities for new product development and improvement. Any disruption or failure in R&D efforts could impact their ability to innovate and maintain a competitive edge in the market.
- Thermo Fisher Scientific Inc operates in highly regulated industries, such as healthcare and pharmaceuticals. Changes in government regulations and policies can significantly impact their operations, requiring compliance adjustments that may incur additional costs or restrict market access.
Opportunities
- The advancement of precision medicine presents an opportunity for Thermo Fisher Scientific Inc as it aligns with their expertise in genomics, proteomics, and other precision research areas. The increasing demand for personalized healthcare solutions can drive the adoption of their products and services.
- Thermo Fisher Scientific Inc can capitalize on the rapid growth of emerging markets, such as Asia-Pacific and Latin America. By expanding their presence in these regions and adapting to local market needs, they can tap into new customer segments and boost their revenue streams.
Threats
- Thermo Fisher Scientific Inc faces fierce competition from other global players and niche market entrants. The competitive landscape poses a threat to their market share, pricing power, and customer acquisition, necessitating consistent innovation, marketing, and strategic efforts to maintain their competitive position.
- Fluctuations in the global economy, currency exchange rates, and geopolitical events can impact Thermo Fisher Scientific Inc's financial performance. Economic uncertainties, recessions, or downturns may reduce customer spending on scientific research and healthcare, affecting their sales and profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.